{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T08:18:21Z","timestamp":1790497101391,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,30]],"date-time":"2027-01-30T00:00:00Z","timestamp":1801267200000},"content-version":"am","delay-in-days":363,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"NIH NCI","doi-asserted-by":"publisher","award":["P30 CA015704"],"award-info":[{"award-number":["P30 CA015704"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015394","name":"American Society for Transplantation and Cellular Therapy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015394","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jtct.2025.10.031","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T05:33:55Z","timestamp":1762320835000},"page":"209.e1-209.e13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["National Landscape of Logistical and Nonmedical Requirements for Transplantation and Cellular Therapy"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1044-7757","authenticated-orcid":false,"given":"Hannah R.","family":"Abrams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Starks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Bandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-Elizabeth M.","family":"Percival","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9268-3341","authenticated-orcid":false,"given":"Roland B.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raya","family":"Mawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4362-7773","authenticated-orcid":false,"given":"Jacob","family":"Appelbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5260-1981","authenticated-orcid":false,"given":"Mohamed L.","family":"Sorror","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna B.","family":"Halpern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jtct.2025.10.031_bib0001","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jtct.2024.09.004","article-title":"Proceedings of the 2024 Third Annual ASTCT-NMDP ACCESS Initiative Workshop","volume":"30","author":"Auletta","year":"2024","journal-title":"Transplantat Cellul Ther"},{"issue":"11","key":"10.1016\/j.jtct.2025.10.031_bib0002","first-page":"666","article-title":"Overcoming barriers to autologous stem cell transplantation in multiple myeloma: recommendations from a multidisciplinary roundtable discussion","volume":"29","author":"Bashir","year":"2023","journal-title":"Transplant Cellul Ther, Off Publicat Am Society Transplantat Cellul Ther"},{"issue":"8","key":"10.1016\/j.jtct.2025.10.031_bib0003","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.bbmt.2009.12.529","article-title":"Access to hematopoietic-cell transplantation in the United States","volume":"16","author":"Majhail","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jtct.2025.10.031_bib0004","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.bbmt.2019.06.012","article-title":"Inferior access to allogeneic transplant in disadvantaged populations: a CIBMTR analysis","volume":"25","author":"Paulson","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2025.10.031_bib0005","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/hematology.2021000259","article-title":"Increasing access to allotransplants in the United States: the impact of race, geography, and socioeconomics","volume":"2021","author":"Hong","year":"2021","journal-title":"Hematology"},{"issue":"23","key":"10.1016\/j.jtct.2025.10.031_bib0006","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1002\/cncr.33826","article-title":"Blood and marrow transplant clinical trials network study 1102 Heralds a new era in hematopoietic cell transplantation in high risk myelodysplastic syndromes: challenges and opportunities in implementation","volume":"127","author":"Warlick","year":"2021","journal-title":"Cancer"},{"issue":"25","key":"10.1016\/j.jtct.2025.10.031_bib0007","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1182\/blood.2024027543","article-title":"Social determinants of health and access to allogeneic hematopoietic cell transplantation for acute myeloid leukemia","volume":"145","author":"Wuliji","year":"2025","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jtct.2025.10.031_bib0008","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jtct.2024.10.014","article-title":"Representativeness of blood and marrow transplant clinical trials network (BMT CTN) trial participants","volume":"31","author":"Kaur","year":"2025","journal-title":"Transplantat Cellul Ther"},{"key":"10.1016\/j.jtct.2025.10.031_bib0009","unstructured":"CIBMTR. Center for International blood and marrow transplant research (CIBMTR) recipient baseline data form. 2020. Available at: https:\/\/cibmtr.org\/Data-Collection-Files\/Forms\/2000R6.pdf."},{"issue":"7","key":"10.1016\/j.jtct.2025.10.031_bib0010","doi-asserted-by":"crossref","first-page":"460.e1","DOI":"10.1016\/j.jtct.2023.04.011","article-title":"Transplantation referral patterns for patients with newly diagnosed higher-risk myelodysplastic syndromes and acute myeloid leukemia at academic and community sites in the Connect\u00ae myeloid disease registry: potential barriers to care","volume":"29","author":"Tomlinson","year":"2023","journal-title":"Transplantat Cellul Ther"},{"issue":"2","key":"10.1016\/j.jtct.2025.10.031_bib0011","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Informat"},{"key":"10.1016\/j.jtct.2025.10.031_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Informat"},{"key":"10.1016\/j.jtct.2025.10.031_bib0013","unstructured":"CIBMTR HCT center-specific survival report methodology (published by NMDP transplant center directory). Accessed May 6, 2025. Available at: https:\/\/www.nmdp.org\/what-we-do\/partnerships\/global-transplant-network\/transplant-center-directory"},{"issue":"1","key":"10.1016\/j.jtct.2025.10.031_bib0014","doi-asserted-by":"crossref","first-page":"50","DOI":"10.12788\/jhm.3681","article-title":"Policy in clinical practice: emergency Medicaid and access to allogeneic stem cell transplant for undocumented immigrants","volume":"17","author":"Simpson","year":"2022","journal-title":"J Hosp Med"},{"issue":"9","key":"10.1016\/j.jtct.2025.10.031_bib0015","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1056\/NEJMp2213751","article-title":"Health care reform and equity for undocumented immigrants \u2014 when crisis meets opportunity","volume":"388","author":"Santos","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2025.10.031_bib0016","unstructured":"Spellman S, Xu S, Allbee-Johnson M, Oloyede T. Current uses and outcomes of cellular therapies in the US: CIBMTR summary slides, 2024."},{"issue":"10435","key":"10.1016\/j.jtct.2025.10.031_bib0017","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0140-6736(24)00319-2","article-title":"Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial","volume":"403","author":"D\u2019Angelo","year":"2024","journal-title":"The Lancet"},{"issue":"3, Supplement","key":"10.1016\/j.jtct.2025.10.031_bib0018","doi-asserted-by":"crossref","first-page":"S626","DOI":"10.1016\/j.jtct.2024.11.013","article-title":"The clinical Til experience in melanoma: past, present, future","volume":"31","author":"Smithy","year":"2025","journal-title":"Transplantat Cellular Therapy"},{"issue":"8","key":"10.1016\/j.jtct.2025.10.031_bib0019","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2308917","article-title":"CD19 CAR T-cell therapy in autoimmune disease \u2014 a case series with Follow-up","volume":"390","author":"M\u00fcller","year":"2024","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jtct.2025.10.031_bib0020","doi-asserted-by":"crossref","first-page":"489.e1","DOI":"10.1016\/j.jtct.2021.03.023","article-title":"Efficacy of allogeneic hematopoietic cell transplantation for autoimmune diseases","volume":"27","author":"Shifa","year":"2021","journal-title":"Transplant Cellul Ther"},{"issue":"2","key":"10.1016\/j.jtct.2025.10.031_bib0021","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/jamaneurol.2020.4025","article-title":"Autologous hematopoietic stem cell transplant in multiple sclerosis: recommendations of the national multiple sclerosis society","volume":"78","author":"Miller","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jtct.2025.10.031_bib0022","article-title":"Proceedings from the reimagining caregiver workshop: addressing caregiver requirements for hematopoietic cell transplant","author":"Preussler","year":"2025","journal-title":"Transplantat Cellul Ther"},{"issue":"6","key":"10.1016\/j.jtct.2025.10.031_bib0023","doi-asserted-by":"crossref","first-page":"349.e1","DOI":"10.1016\/j.jtct.2025.02.009","article-title":"Awakening from REMS: ASTCT 80\/20 ongoing recommendations for safe use of chimeric antigen receptor T cells","volume":"31","author":"Locke","year":"2025","journal-title":"Transplantat Cellul Ther"},{"key":"10.1016\/j.jtct.2025.10.031_bib0024","unstructured":"Research C for BE and. FDA Eliminates Risk Evaluation and Mitigation Strategies (REMS) for Autologous Chimeric Antigen Receptor (CAR) T cell Immunotherapies. FDA. 2025. Accessed June 27, 2025. Available at:https:\/\/www.fda.gov\/vaccines-blood-biologics\/safety-availability-biologics\/fda-eliminates-risk-evaluation-and-mitigation-strategies-rems-autologous-chimeric-antigen-receptor"},{"issue":"11","key":"10.1016\/j.jtct.2025.10.031_bib0025","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/sj.bmt.1703676","article-title":"Lack of caregivers limits use of outpatient hematopoietic stem cell transplant program","volume":"30","author":"Frey","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"Supplement 1","key":"10.1016\/j.jtct.2025.10.031_bib0026","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1182\/blood-2021-153120","article-title":"Quality of Life and Caregiver Burden in Patients and Their Caregivers Undergoing Outpatient Autologous Stem Cell Transplantation Compared to Inpatient Transplantation","volume":"138","author":"Prica","year":"2021","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jtct.2025.10.031_bib0027","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1200\/OP.22.00315","article-title":"Chimeric antigen receptor T-cell therapies: barriers and solutions to access","volume":"18","author":"Mikhael","year":"2022","journal-title":"JCO Oncol Pract"},{"issue":"6","key":"10.1016\/j.jtct.2025.10.031_bib0028","article-title":"Family caregiver experiences in the inpatient and outpatient reduced-intensity conditioning allogeneic hematopoietic cell transplantation settings: a qualitative study","volume":"30","author":"Gray","year":"2024","journal-title":"Transplantat Cellul Ther"},{"key":"10.1016\/j.jtct.2025.10.031_bib0029","unstructured":"Preussler JM, DeSalvo AM, Tweeten B, O\u2019Brien B, Schoeppner K, Coles JAS. Patient Perspectives on Post-Allogeneic Hematopoietic Cell Transplant Caregiver Requirements. In: Tandem Meetings; 2024. Accessed July 31, 2024.https:\/\/tandem.confex.com\/tandem\/2024\/meetingapp.cgi\/Paper\/24032"},{"issue":"11","key":"10.1016\/j.jtct.2025.10.031_bib0030","first-page":"723","article-title":"Can you spare 100 days? The allogeneic hematopoietic cell transplant caregiver requirement from the perspective of social workers","volume":"32","author":"Preussler","year":"2024","journal-title":"Support Care Cancer"},{"issue":"11","key":"10.1016\/j.jtct.2025.10.031_bib0031","first-page":"4253","article-title":"Caregiver availability and patient access to hematopoietic cell transplantation: social worker perspectives inform practice","volume":"27","author":"Preussler","year":"2019","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jtct.2025.10.031_bib0032","article-title":"The caregiver paradigm in hematopoietic cell transplant: current and future directions","author":"Tweeten","year":"2025","journal-title":"Transplantat Cellul Ther, Off Publicat Am Society Transplant Cellul Ther"},{"key":"10.1016\/j.jtct.2025.10.031_bib0033","unstructured":"O\u2019Shea PJ, Johnson, PC, El-Jawahri, A, and Leblanc TW. Unmet needs and lived experience of patients receiving CAR T-cell therapy. Leukemia & Lymphoma. 1-11. 10.1080\/10428194.2025.2455488"},{"key":"10.1016\/j.jtct.2025.10.031_bib0034","unstructured":"Reblin M, Liang, Irene, Tay, Djin L., Kirtane, Kedar, and Ketcher D. The patient and caregiver experience of CAR T-cell therapy: a qualitative analysis. J Psychosoc Oncol. 1-11. 10.1080\/07347332.2025.2460060"},{"key":"10.1016\/j.jtct.2025.10.031_bib0035","unstructured":"The Recognize, Assist, Include, Support, and Engage (RAISE) Act, Family Caregiving Advisory Council, &, The Advisory Council to Support Grandparents Raising Grandchildren. 2022 National Strategy to Support Family Caregivers. Published online 2022. https:\/\/acl.gov\/sites\/default\/files\/RAISE_SGRG\/NatlStrategyToSupportFamilyCaregivers-2.pdf Accessed May 7, 2025."},{"key":"10.1016\/j.jtct.2025.10.031_bib0036","unstructured":"National Alliance for Caregiving. Transplant caregiving in the U.S.: a call for system change.; 2023. Available at: https:\/\/www.caregiving.org\/wp-content\/uploads\/2023\/11\/NAC_TransplantCaregiversReport-FINAL.pdf"},{"issue":"3","key":"10.1016\/j.jtct.2025.10.031_bib0037","first-page":"1167","article-title":"Patient housing barriers to hematopoietic cell transplantation: results from a mixed-methods study of transplant center social workers","volume":"24","author":"Preussler","year":"2016","journal-title":"Supp Care Cancer"},{"issue":"9","key":"10.1016\/j.jtct.2025.10.031_bib0038","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jtct.2024.06.012","article-title":"Timing of toxicities and non-relapse mortality following CAR T therapy in myeloma","volume":"30","author":"Wesson","year":"2024","journal-title":"Transplant Cellul Ther"},{"issue":"20","key":"10.1016\/j.jtct.2025.10.031_bib0039","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1182\/bloodadvances.2023012549","article-title":"Optimizing the post-CAR T monitoring period in recipients of axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucel","volume":"8","author":"Ahmed","year":"2024","journal-title":"Blood Adv"},{"issue":"7","key":"10.1016\/j.jtct.2025.10.031_bib0040","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.bbmt.2016.03.019","article-title":"Association of distance from transplant center and place of residence on outcomes after allogeneic hematopoietic cell transplantation","volume":"22","author":"Khera","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2025.10.031_bib0041","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.bbmt.2009.10.028","article-title":"Outcomes of hematological malignancies after unrelated donor hematopoietic-cell transplantation according to place of residence","volume":"16","author":"Loberiza","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.10.031_bib0042","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2147\/CLEP.S210456","article-title":"Longer distance to specialized treatment centers does not adversely affect treatment intensity or outcomes in adult acute myeloid leukemia patients. a Danish national population-based cohort study","volume":"11","author":"T\u00f8stesen","year":"2019","journal-title":"Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.jtct.2025.10.031_bib0043","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1001\/jamaoncol.2024.5786","article-title":"Shared local oncology care after allogeneic hematopoietic cell transplantation: a randomized clinical trial","volume":"11","author":"Abel","year":"2025","journal-title":"JAMA Oncol"},{"issue":"16","key":"10.1016\/j.jtct.2025.10.031_bib0044","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.3390\/cancers15164108","article-title":"Telemedicine in hematopoietic cell transplantation and chimeric antigen receptor-T cell therapy","volume":"15","author":"Gandhi","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.jtct.2025.10.031_bib0045","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1038\/s41409-020-0919-0","article-title":"The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy","volume":"55","author":"Ljungman","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2025.10.031_bib0046","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDccon2100012","article-title":"Can I safely discharge a patient with a substance use disorder home with a peripherally inserted central catheter?","volume":"1","author":"Appa","year":"2022","journal-title":"NEJM Evidence"},{"issue":"2","key":"10.1016\/j.jtct.2025.10.031_bib0047","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1378\/chest.94.2.432","article-title":"Fatal aspergillosis associated with smoking contaminated marijuana, in a marrow transplant recipient","volume":"94","author":"Hamadeh","year":"1988","journal-title":"CHEST"},{"issue":"2","key":"10.1016\/j.jtct.2025.10.031_bib0048","first-page":"S371","article-title":"Medication adherence patterns following hematopoietic cell transplantation (HCT)","volume":"31","author":"Newcomb","year":"2025","journal-title":"Transplantat Cellul Ther, Off Publicat Am Society Transplant Cellul Ther"},{"issue":"11","key":"10.1016\/j.jtct.2025.10.031_bib0049","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jtct.2023.08.007","article-title":"Assessing medicaid coverage for hematopoietic cell transplantation and chimeric antigen receptor T cell therapy: a project from the American Society for Transplantation and Cellular Therapy and the National Marrow Donor Program ACCESS Initiative","volume":"29","author":"Auletta","year":"2023","journal-title":"Transplantat Cellul Ther"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663672501543X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663672501543X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:20:41Z","timestamp":1777638041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266663672501543X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S266663672501543X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.10.031","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"National Landscape of Logistical and Nonmedical Requirements for Transplantation and Cellular Therapy","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.10.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Transplantation and Cellular Therapy. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}